HCA Healthcare (NYSE:HCA) PT Raised to $375.00 at Deutsche Bank Aktiengesellschaft

HCA Healthcare (NYSE:HCA) had its price objective increased by investment analysts at Deutsche Bank Aktiengesellschaft from $359.00 to $375.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would suggest a potential upside of 14.85% from the stock’s current price.

HCA has been the topic of several other reports. Barclays upped their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a report on Monday, April 29th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, June 16th. Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 price objective on shares of HCA Healthcare in a research report on Wednesday, April 10th. Robert W. Baird began coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 target price for the company. Finally, Wells Fargo & Company raised their price objective on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Four analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $326.53.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock traded down $16.77 during trading hours on Friday, reaching $326.52. The stock had a trading volume of 1,153,194 shares, compared to its average volume of 1,066,239. The firm has a market capitalization of $85.52 billion, a PE ratio of 16.28, a PEG ratio of 1.58 and a beta of 1.69. The stock’s 50 day moving average is $324.71 and its 200 day moving average is $316.70. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare has a twelve month low of $215.96 and a twelve month high of $344.20.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter in the previous year, the company earned $4.93 earnings per share. The company’s quarterly revenue was up 11.2% on a year-over-year basis. Equities analysts expect that HCA Healthcare will post 20.92 earnings per share for the current fiscal year.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,600 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares in the company, valued at approximately $10,544,316. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the sale, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at $6,977,880. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock valued at $3,921,929 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of HCA Healthcare

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in HCA Healthcare by 0.4% in the first quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after buying an additional 60,304 shares during the last quarter. Sanders Capital LLC increased its holdings in HCA Healthcare by 4.2% in the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after buying an additional 456,738 shares during the last quarter. Wellington Management Group LLP grew its holdings in HCA Healthcare by 1.7% during the fourth quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after purchasing an additional 170,560 shares during the last quarter. Royal Bank of Canada grew its holdings in HCA Healthcare by 35.7% during the fourth quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors grew its holdings in HCA Healthcare by 57.5% during the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.